• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溃疡性直肠炎的近端病变扩展及相关预测因素

Proximal disease extension and related predicting factors in ulcerative proctitis.

作者信息

Kim Bun, Park Soo Jung, Hong Sung Pil, Kim Tae Il, Kim Won Ho, Cheon Jae Hee

机构信息

Department of Internal Medicine and Institute of Gastroenterology, Yonsei University College of Medicine , Seoul , Korea.

出版信息

Scand J Gastroenterol. 2014 Feb;49(2):177-83. doi: 10.3109/00365521.2013.867360. Epub 2013 Dec 11.

DOI:10.3109/00365521.2013.867360
PMID:24325564
Abstract

OBJECTIVE

Ulcerative colitis usually involves the rectum, may extend in a proximal and continuous fashion to involve varying portions of the bowel. However, the risk factors predictive of proximal extension have yet to be determined. The aim of this study was to evaluate both the natural course of disease and the risk factors influencing the proximal disease extension in ulcerative proctitis.

MATERIAL AND METHODS

We retrospectively analyzed 98 patients with ulcerative proctitis at the time of diagnosis who were regularly followed and underwent sigmoidoscopy or colonoscopy between January 2000 and December 2007.

RESULTS

The mean duration of follow-up was 109.2 ± 49.5 months. A total of 27 (27.6%) patients experienced proximal disease extension. Mayo scores were significantly higher in the extension group compared with patients whose ulcerative proctitis did not extend proximally (p < 0.001). Corticosteroid use at initial diagnosis was also more frequent in the extension group (p = 0.026). In addition, chronic, continuous disease activation within 6 months of the initial diagnosis was significantly higher in the extension group (p < 0.001), as was disease relapse and the number of hospitalizations over the entire follow-up period (p < 0.001 and p = 0.002). According to multivariate analysis, disease extension after the initial diagnosis was associated with chronic disease activation, disease relapse and hospitalization (p = 0.030, p = 0.042 and p = 0.044, respectively).

CONCLUSION

Increased severity of disease upon diagnosis of ulcerative proctitis was associated with a higher probability of proximal disease extension during the follow-up period. Moreover, those with disease extension were more likely to experience relapse and to be hospitalized, indicating poor prognosis.

摘要

目的

溃疡性结肠炎通常累及直肠,可能以向近端连续的方式扩展至肠道的不同部位。然而,预测近端扩展的危险因素尚未确定。本研究的目的是评估溃疡性直肠炎的疾病自然进程以及影响近端疾病扩展的危险因素。

材料与方法

我们回顾性分析了98例诊断为溃疡性直肠炎且在2000年1月至2007年12月期间定期随访并接受乙状结肠镜检查或结肠镜检查的患者。

结果

平均随访时间为109.2±49.5个月。共有27例(27.6%)患者出现近端疾病扩展。与溃疡性直肠炎未向近端扩展的患者相比,扩展组的梅奥评分显著更高(p<0.001)。扩展组在初始诊断时使用皮质类固醇的频率也更高(p=0.026)。此外,扩展组在初始诊断后6个月内慢性、持续性疾病激活显著更高(p<0.001),整个随访期间的疾病复发和住院次数也是如此(p<0.001和p=0.002)。根据多变量分析,初始诊断后的疾病扩展与慢性疾病激活、疾病复发和住院相关(分别为p=0.030、p=0.042和p=0.044)。

结论

溃疡性直肠炎诊断时疾病严重程度增加与随访期间近端疾病扩展的可能性更高相关。此外,疾病扩展的患者更可能经历复发和住院,提示预后不良。

相似文献

1
Proximal disease extension and related predicting factors in ulcerative proctitis.溃疡性直肠炎的近端病变扩展及相关预测因素
Scand J Gastroenterol. 2014 Feb;49(2):177-83. doi: 10.3109/00365521.2013.867360. Epub 2013 Dec 11.
2
The natural history of ulcerative proctitis: a multicenter, retrospective study. Gruppo di Studio per le Malattie Infiammatorie Intestinali (GSMII).溃疡性直肠炎的自然病史:一项多中心回顾性研究。肠道炎症性疾病研究组(GSMII)
Am J Gastroenterol. 2000 Feb;95(2):469-73. doi: 10.1111/j.1572-0241.2000.t01-1-01770.x.
3
Appendiceal orifice inflammation is associated with proximal extension of disease in patients with ulcerative colitis.阑尾口炎症与溃疡性结肠炎患者疾病的近端延伸有关。
Colorectal Dis. 2016 Aug;18(8):O278-82. doi: 10.1111/codi.13435.
4
Clinical pattern and progression of ulcerative proctitis in the Japanese population: a retrospective study of incidence and risk factors influencing progression.日本人群中溃疡性直肠炎的临床模式与病程:一项关于发病率及影响病程进展的危险因素的回顾性研究
Colorectal Dis. 2016 Mar;18(3):O97-O102. doi: 10.1111/codi.13237.
5
[Course and natural history of idiopathic ulcerative proctitis in adults].[成人特发性溃疡性直肠炎的病程及自然史]
Ann Ital Chir. 2002 Mar-Apr;73(2):155-8; discussion 158-9.
6
Change in the extent of colonic involvement in ulcerative colitis: a colonoscopic study.溃疡性结肠炎结肠受累范围的变化:一项结肠镜研究
Am J Gastroenterol. 1987 Oct;82(10):1046-51.
7
[Frequency of proximal colonic extension of distal ulcerative colitis].[远端溃疡性结肠炎近端结肠扩展的频率]
Tunis Med. 2007 Aug;85(8):669-72.
8
Factors associated with disease evolution in Greek patients with inflammatory bowel disease.希腊炎症性肠病患者疾病进展的相关因素。
BMC Gastroenterol. 2006 Jul 25;6:21. doi: 10.1186/1471-230X-6-21.
9
Endoscopic progression of ulcerative proctitis to proximal disease. Can we identify predictors of progression?溃疡性直肠炎向近端疾病的内镜进展。我们能否识别出进展的预测因素?
Scand J Gastroenterol. 2018 Oct-Nov;53(10-11):1286-1290. doi: 10.1080/00365521.2018.1524026. Epub 2018 Oct 23.
10
Extension of ulcerative colitis.溃疡性结肠炎的扩展
Turk J Gastroenterol. 2011 Aug;22(4):382-7. doi: 10.4318/tjg.2011.0241.

引用本文的文献

1
Systematic review with meta-analysis: Medical therapies for treatment of ulcerative proctitis.系统评价与荟萃分析:治疗溃疡性直肠炎的医学疗法。
Aliment Pharmacol Ther. 2023 Oct;58(8):740-762. doi: 10.1111/apt.17666. Epub 2023 Aug 17.
2
Successful Treatment of Refractory Ulcerative Proctitis in a Pediatric Patient Using Topical Tacrolimus.局部使用他克莫司成功治疗一名儿科患者的难治性溃疡性直肠炎
JPGN Rep. 2020 Sep 22;1(2):e012. doi: 10.1097/PG9.0000000000000012. eCollection 2020 Nov.
3
Ulcerative colitis progression: a retrospective analysis of disease burden using electronic medical records.
溃疡性结肠炎的进展:基于电子病历的疾病负担回顾性分析。
Ups J Med Sci. 2022 Oct 18;127. doi: 10.48101/ujms.v127.8833. eCollection 2022.
4
Factors Predictive of Proximal Disease Extension and Clinical Course of Patients Initially Diagnosed with Ulcerative Proctitis in an IBD Referral Center.在炎症性肠病(IBD)转诊中心,最初诊断为溃疡性直肠炎的患者中,预测近端疾病进展和临床病程的因素。
Turk J Gastroenterol. 2022 Apr;33(4):320-328. doi: 10.5152/tjg.2022.21124.
5
Clinical predictors for a complicated course of disease in an inception cohort of patients with ulcerative colitis: results from the prospective, observational EPICOL study.溃疡性结肠炎患者队列的临床预测因子:前瞻性、观察性 EPICOL 研究结果。
Int J Colorectal Dis. 2022 Feb;37(2):485-493. doi: 10.1007/s00384-022-04098-7. Epub 2022 Jan 27.
6
When disease extent is not always a key parameter: Management of refractory ulcerative proctitis.当疾病范围并非总是关键参数时:难治性溃疡性直肠炎的管理
Curr Res Pharmacol Drug Discov. 2021 Dec 11;3:100071. doi: 10.1016/j.crphar.2021.100071. eCollection 2022.
7
Improving prediction of disease outcome for inflammatory bowel disease: progress through systems medicine.通过系统医学改善炎症性肠病疾病结局的预测:进展。
Expert Rev Clin Immunol. 2021 Aug;17(8):871-881. doi: 10.1080/1744666X.2021.1945442. Epub 2021 Jun 28.
8
Prognostic Value of Terminal Ileal Inflammation in Patients with Ulcerative Colitis.溃疡性结肠炎患者末端回肠炎的预后价值。
Gut Liver. 2021 Nov 15;15(6):858-866. doi: 10.5009/gnl20294.
9
First United Arab Emirates consensus on diagnosis and management of inflammatory bowel diseases: A 2020 Delphi consensus.**阿联酋第一次炎症性肠病诊断和管理共识:2020 年德尔菲共识**
World J Gastroenterol. 2020 Nov 21;26(43):6710-6769. doi: 10.3748/wjg.v26.i43.6710.
10
Clinical Significance of Residual Nonrectal Inflammation in Ulcerative Colitis Patients in Clinical Remission.溃疡性结肠炎患者临床缓解时直肠外残留炎症的临床意义
Gut Liver. 2021 May 15;15(3):401-409. doi: 10.5009/gnl20078.